Skip To Main Content
This website is intended exclusively for the Registered Medical Practitioners in India.

Management of End-stage renal disease: Transplant Vs. Dialysis

Worldwide, around 26 lakh individuals are affected by end-stage renal disease (ESRD), and in India, the incidence rate is 187 cases per lakh people. This adds to the escalating global health burden associated with the disease. Over 20% of ESRD patients remain receiving renal replacement treatment over the long term. In the Indian context, the selection of treatment modalities for ESRD commonly involves hemodialysis as the primary choice, followed by transplantation. Despite obstacles like insufficient health insurance coverage and the considerably high recurring costs, there is a growing trend in the utilization of peritoneal dialysis (PD).

For individuals with ESRD, renal replacement therapy, such as kidney transplantation, is imperative. The procedures involved are shaped by a range of factors, encompassing state welfare funding, protocols for declaring brain death, personal religious beliefs, the availability of technical expertise, and the affordability of immunosuppressive medications.

In this episode of TRANSFORuM, Dr. Sudeep Singh Sachdev discusses the topic of "Management of End-Stage Renal Disease: Transplant vs. Dialysis." The speaker goes over the factors that influence the decision to choose between transplant and dialysis as treatment modalities, gives a general overview of end stage renal disease and its various treatment options, and discusses the results of each option.

Interested to know more about our products?

Request for samples here